Search
Saccharin
go.drugbank.com/drugs/DB12418InvestigationalSaccharin has been investigated for the treatment of Hypertension and Hyperglycemia.
Categories: Compounds used in a research, industrial, or household settingMuplestim
go.drugbank.com/drugs/DB12431InvestigationalMuplestim is under investigation in clinical trial NCT00002258 (A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL
Steviolbioside
go.drugbank.com/drugs/DB12434ApprovedWithdrawnSteviolbioside has been used in trials studying the treatment of HIV-1 Infection.
Categories: Compounds used in a research, industrial, or household settingIoforminol
go.drugbank.com/drugs/DB12439InvestigationalIoforminol has been used in trials studying the diagnostic of Cardio Renal Safety in High-risk Elderly Subjects Undergoing a Coronary CATH With or Without PCI.
Lynestrenol
go.drugbank.com/drugs/DB12474ApprovedWithdrawnLynestrenol is a progestin and prodrug of [norethisterone].
Ozone
go.drugbank.com/drugs/DB12510InvestigationalOzone has been used in trials studying the treatment of Mild Asthma and Primary Apical Periodontite.
Categories: Compounds used in a research, industrial, or household settingPiperine
go.drugbank.com/drugs/DB12582InvestigationalBioperine has been used in trials studying the treatment of Multiple Myeloma and Deglutition Disorders.
Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesPentetreotide
go.drugbank.com/drugs/DB12602ApprovedWithdrawnPentetreotide has been used in trials studying the diagnosis of Cushing's syndrome.
Categories: Compounds used in a research, industrial, or household settingEbselen
go.drugbank.com/drugs/DB12610InvestigationalEbselen has been investigated for the treatment and basic science of Meniere's Disease, Type 2 Diabetes Mellitus, and Type 1 Diabetes Mellitus.
Categories: Compounds used in a research, industrial, or household settingNavicixizumab
go.drugbank.com/drugs/DB12634InvestigationalNavicixizumab is under investigation in clinical trial NCT02298387 (A Phase 1 Study of Navicixizumab in Subjects With Solid Tumors).